VSEE HEALTH INC (VSEE) Fundamental Analysis & Valuation

NASDAQ:VSEE • US92919Y1029

Current stock price

0.2402 USD
+0.01 (+2.21%)
At close:
0.2375 USD
0 (-1.12%)
After Hours:

This VSEE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. VSEE Profitability Analysis

1.1 Basic Checks

  • VSEE had negative earnings in the past year.
  • VSEE had a negative operating cash flow in the past year.
  • In the past 5 years VSEE always reported negative net income.
  • In the past 5 years VSEE always reported negative operating cash flow.
VSEE Yearly Net Income VS EBIT VS OCF VS FCFVSEE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M -50M

1.2 Ratios

  • VSEE has a worse Return On Assets (-65.64%) than 85.71% of its industry peers.
  • With a Return On Equity value of -269.84%, VSEE is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -65.64%
ROE -269.84%
ROIC N/A
ROA(3y)-273.75%
ROA(5y)-172.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VSEE Yearly ROA, ROE, ROICVSEE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 100K 200K 300K

1.3 Margins

  • With a Gross Margin value of 50.32%, VSEE is not doing good in the industry: 65.71% of the companies in the same industry are doing better.
  • VSEE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VSEE Yearly Profit, Operating, Gross MarginsVSEE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 -200 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. VSEE Health Analysis

2.1 Basic Checks

  • VSEE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • VSEE has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for VSEE has been reduced compared to a year ago.
VSEE Yearly Shares OutstandingVSEE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 10M 20M 30M
VSEE Yearly Total Debt VS Total AssetsVSEE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -5.93, we must say that VSEE is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of VSEE (-5.93) is worse than 80.00% of its industry peers.
  • VSEE has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
  • VSEE has a Debt to Equity ratio of 0.49. This is in the lower half of the industry: VSEE underperforms 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Altman-Z -5.93
ROIC/WACCN/A
WACC7.99%
VSEE Yearly LT Debt VS Equity VS FCFVSEE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 0.51 indicates that VSEE may have some problems paying its short term obligations.
  • VSEE's Current ratio of 0.51 is on the low side compared to the rest of the industry. VSEE is outperformed by 91.43% of its industry peers.
  • VSEE has a Quick Ratio of 0.51. This is a bad value and indicates that VSEE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • VSEE's Quick ratio of 0.51 is on the low side compared to the rest of the industry. VSEE is outperformed by 91.43% of its industry peers.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.51
VSEE Yearly Current Assets VS Current LiabilitesVSEE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. VSEE Growth Analysis

3.1 Past

  • VSEE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 83.77%, which is quite impressive.
  • Looking at the last year, VSEE shows a very strong growth in Revenue. The Revenue has grown by 40.27%.
EPS 1Y (TTM)83.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.39%
Revenue 1Y (TTM)40.27%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1.72%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y33.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year30.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VSEE Yearly Revenue VS EstimatesVSEE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 5M 10M 15M 20M
VSEE Yearly EPS VS EstimatesVSEE Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.1 -0.2 -0.3

More info and screens

Find the best growth stocksShow best growing peers

0

4. VSEE Valuation Analysis

4.1 Price/Earnings Ratio

  • VSEE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VSEE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VSEE Price Earnings VS Forward Price EarningsVSEE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VSEE Per share dataVSEE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VSEE Dividend Analysis

5.1 Amount

  • VSEE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VSEE Fundamentals: All Metrics, Ratios and Statistics

VSEE HEALTH INC

NASDAQ:VSEE (4/14/2026, 8:00:02 PM)

After market: 0.2375 0 (-1.12%)

0.2402

+0.01 (+2.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-31
Earnings (Next)N/A
Inst Owners11.31%
Inst Owner Change0%
Ins Owners16.68%
Ins Owner Change7.63%
Market Cap11.36M
Revenue(TTM)14.62M
Net Income(TTM)-14.71M
Analysts82.86
Price TargetN/A
Short Float %2.56%
Short Ratio1.76
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.78
P/FCF N/A
P/OCF N/A
P/B 2.08
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.67
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.31
BVpS0.12
TBVpS-0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -65.64%
ROE -269.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.32%
FCFM N/A
ROA(3y)-273.75%
ROA(5y)-172.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.16%
Cap/Sales 0.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.51
Altman-Z -5.93
F-Score5
WACC7.99%
ROIC/WACCN/A
Cap/Depr(3y)206.54%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.27%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.39%
EPS Next Y33.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)40.27%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1.72%
Revenue Next Year30.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-66.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year65.51%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y40.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.48%
OCF growth 3YN/A
OCF growth 5YN/A

VSEE HEALTH INC / VSEE Fundamental Analysis FAQ

What is the fundamental rating for VSEE stock?

ChartMill assigns a fundamental rating of 1 / 10 to VSEE.


What is the valuation status of VSEE HEALTH INC (VSEE) stock?

ChartMill assigns a valuation rating of 0 / 10 to VSEE HEALTH INC (VSEE). This can be considered as Overvalued.


Can you provide the profitability details for VSEE HEALTH INC?

VSEE HEALTH INC (VSEE) has a profitability rating of 0 / 10.